Human Epidermal Growth Factor Receptor 2 (HER-2/neu)-Directed Therapy for Rare Metastatic Epithelial Tumors with HER-2 Amplification

por Shin, Daniel Sanghoon, Sherry, Timothy, Kallen, Michael E., Wong, Steven, Drakaki, Alexandra
Publicado 2016

Disseminated histoplasmosis mimicking hematologic malignancy in a patient with human immunodeficiency virus

por Kallen, Michael E., Khalil, Ahmed, DeRosa, Peter Anthony, Baer, Maria R.
Publicado 2022

Hyperprogression of Liver Metastasis With Neoadjuvant Immunotherapy for Soft Tissue Sarcoma

por Chan, Abigail S, Ng, Vincent Y, Snider, James, Kallen, Michael E, Miller, Kenneth D
Publicado 2020

Embryonal Rhabdomyosarcoma with Posttherapy Cytodifferentiation and Aggressive Clinical Course

por Jeyaraju, Maniraj, Macatangay, Regina Ann, Munchel, Ashley Taylor-King, York, Teresa Anne, Montgomery, Elizabeth A., Kallen, Michael E.
Publicado 2021

Therapy-related B-lymphoblastic leukemia after multiple myeloma

por Kallen, Michael E., Koka, Rima, Singh, Zeba N., Ning, Yi, Kocoglu, Mehmet H., Badros, Ashraf Z., Niyongere, Sandrine, Duong, Vu H., Emadi, Ashkan, Baer, Maria R.
Publicado 2022

Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD)

por Kline, Kathryn, Chen, Wengen, Kallen, Michael E., Koka, Rima, Omili, Destiny, Fan, Xiaoxuan, Iraguha, Thierry, Gebru, Etse, Dishanthan, Nishanthini, Baker, Jillian M., Dietze, Kenneth A., Yared, Jean A., Hankey, Kim, Dahiya, Saurabh, Niederhaus, Silke V., Dunleavy, Kieron, Hardy, Nancy M., Luetkens, Tim, Rapoport, Aaron P., Atanackovic, Djordje
Publicado 2023